Mutual of America Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.52M | Buy |
43,303
+3,680
| +9% | +$384K | 0.05% | 476 |
|
|
2025
Q1 | $4.62M | Buy |
39,623
+136
| +0.3% | +$15.9K | 0.05% | 455 |
|
|
2024
Q4 | $3.34M | Sell |
39,487
-35
| -0.1% | -$2.96K | 0.04% | 648 |
|
|
2024
Q3 | $3.55M | Sell |
39,522
-371
| -0.9% | -$33.3K | 0.04% | 646 |
|
|
2024
Q2 | $3.21M | Sell |
39,893
-1,727
| -4% | -$139K | 0.04% | 677 |
|
|
2024
Q1 | $3.32M | Buy |
41,620
+7,042
| +20% | +$562K | 0.04% | 679 |
|
|
2023
Q4 | $2.75M | Sell |
34,578
-1,590
| -4% | -$127K | 0.03% | 758 |
|
|
2023
Q3 | $2.53M | Sell |
36,168
-2,152
| -6% | -$150K | 0.03% | 755 |
|
|
2023
Q2 | $2.75M | Sell |
38,320
-2,925
| -7% | -$210K | 0.03% | 774 |
|
|
2023
Q1 | $2.54M | Buy |
41,245
+1,993
| +5% | +$123K | 0.03% | 804 |
|
|
2022
Q4 | $3.03M | Buy |
39,252
+17,456
| +80% | +$1.35M | 0.04% | 717 |
|
|
2022
Q3 | $973K | Buy |
+21,796
| New | +$973K | 0.01% | 1028 |
|